A Better Way to Handle Senescent Cells

In longevity science, few topics receive as much attention today as cellular senescence. If you follow health news, podcasts, or online longevity discussions, you have likely heard senescent cells described as "zombie cells". The common story portrays them as entirely harmful: damaged cells that refuse to die, lingering in tissues and spreading inflammation to their healthy neighbors.

Because of this reputation, a major focus in anti-aging research has centered on finding ways to hunt down and destroy these cells. Treatments designed to kill them off entirely are known as senolytics. The logic seems simple enough: if these cells cause problems as we age, wiping them out should help us stay young.

Biology is rarely that simple. Cells do not exist without a purpose, and cellular senescence is an essential process that your body uses to protect and repair itself.

At Rejuvant, our research team works closely with our Chief Scientific Officer, Dr. Brian Kennedy, who spent years investigating the basic biology of aging at the Buck Institute for Research on Aging and the National University of Singapore. When looking closely at the data, a more balanced picture emerges. Senescent cells do important work in human tissue. The trouble is not that these cells exist; the trouble lies in the toxic chemical signals they produce when they hang around for too long.

Understanding how these cells function helps explain why managing their chemical output with controlled-release CaAKG offers a practical way to support healthy aging.

To understand senescence, we have to look at how cells normally behave throughout your life. Most healthy cells in your body divide regularly to replace old or worn-out tissue. Every time a cell divides, it copies its DNA. Over decades, physical stress, oxidative damage, and environmental toxins take a toll on those genetic strands.

When a cell suffers severe damage to its DNA, it faces a critical choice. If it continues to divide with broken genetic code, it runs the risk of mutating and turning into a cancerous tumor. To prevent this danger, the cell hits an emergency brake. It permanently stops dividing, entering a stable state known as senescence.

In this sense, senescence is one of your body’s primary defense systems against cancer. By locking damaged cells in place, your tissues prevent broken cells from multiplying out of control.

Senescent cells also perform essential work in daily tissue repair. When you cut your skin or pull a muscle, senescent cells appear briefly at the site of the injury. They secrete specific chemical signals that direct other cells to lay down collagen, close the wound, and rebuild local structures. Once the repair is complete, your immune system clears them away.

Senescent cells also play vital roles during early human development, helping sculpt tissues and organs before birth.

These cells are an active part of your body's survival toolkit. The goal of healthy aging should be to work alongside these natural processes rather than attempting to wipe them out completely.

If senescent cells are so helpful for wound repair and cancer prevention, why do they have such a bad reputation?

The issue comes down to time. In a young, healthy body, senescent cells appear, send out their repair signals, and then get removed by immune cells. As we grow older, our immune system becomes slower and less efficient at clearing these cells away. As a result, senescent cells begin to accumulate in tissues across the body, including the skin, joints, blood vessels, and brain.

Even though these cells can no longer divide, they remain metabolically active. When they stay in your tissues for months or years, their signaling changes from helpful to destructive.

They begin pumping out a complex mixture of inflammatory molecules known as the Senescence-Associated Secretory Phenotype, or SASP for short.

The SASP includes several damaging components:

When senescent cells continuously release this mixture, it acts like smoke filling a room. Healthy neighboring cells that come into contact with the SASP experience stress and can even be forced into senescence themselves.

Over time, this steady release of inflammatory compounds drives a chronic state of body-wide inflammation known as inflammaging. This background inflammation wears out blood vessels, stiffens connective tissue, drains energy, and speeds up the biological aging clock.

Because the SASP causes so much collateral damage, many researchers have focused on developing senolytic compounds designed to kill senescent cells. Common examples tested in laboratories include drugs like dasatinib and plant compounds like quercetin and fisetin.

While senolytics have shown interesting results in animal studies, wiping out senescent cells carries potential downsides. If you eliminate these cells completely, you risk disrupting your body’s ability to heal wounds efficiently, rebuild damaged muscle, and signal the immune system when local repairs are needed. Additionally, constantly destroying cells places a higher demand on your stem cell reserves to generate replacements, which can lead to stem cell exhaustion over time.

This has led longevity scientists to explore an alternative strategy: senomodulation.

A senomodulator (sometimes called a senomorphic) does not seek to kill the cell. Instead, it works by calming the cell down and turning off its harmful secretions. It allows the senescent cell to remain quietly in place, where it can still assist with tissue repair if called upon, while preventing it from releasing the destructive SASP signals that damage neighboring tissue.

Regulating what senescent cells release provides a balanced way to lower systemic inflammation without compromising your body's natural defense and repair mechanisms.

This regulatory strategy is supported by landmark research on calcium alpha-ketoglutarate, or CaAKG.

In a major study published in the journal Cell Metabolism by Shahmirzadi and colleagues—co-led by Dr. Brian Kennedy—researchers investigated the long-term effects of CaAKG on aging mice. The findings provided clear insight into how this metabolite handles cellular senescence.

When the scientists examined tissues from the animals treated with CaAKG, they noticed something unexpected. The total number of senescent cells had not changed significantly compared to untreated animals. CaAKG was not acting as a senolytic; it was not killing the cells off.

However, the animals taking CaAKG showed dramatic reductions in systemic inflammatory markers, improved physical health, reduced frailty, and longer healthspans.

To understand why, the researchers ran cell culture experiments using human fibroblasts subjected to radiation stress, a standard method to induce cellular senescence.

The data revealed the exact mechanism: while the cells still entered senescence to protect against DNA damage, CaAKG dramatically suppressed their SASP secretions. Specifically, the treatment led to a sharp drop in inflammatory cytokines like IL-6, preventing the cells from releasing toxic signals into their environment.

At the same time, the research showed that CaAKG helped promote the production of interleukin-10 (IL-10), an anti-inflammatory cytokine that calms immune activity and protects tissues from chronic stress.

CaAKG does not eliminate your body's protective cells. It steps in to silence their harmful output, restoring a balanced, peaceful environment inside your tissues.

Translating this cellular science into daily life shows how managing senescence supports your everyday health, physical comfort, and long-term vitality:

If alpha-ketoglutarate can help quiet senescent cells, you might wonder why an ordinary, inexpensive AKG powder from a health store cannot achieve the same result.

The challenge comes down to how your digestive system handles the raw nutrient.

Alpha-ketoglutarate is a natural intermediate in cellular energy production. When taken in a plain, unformulated powder or standard capsule, it faces rapid clearance. Standard AKG has a half-life of under five minutes in the bloodstream.

Even more challenging, the cells of your upper small intestine use free AKG as an immediate fuel source. Roughly 80% of an oral dose of unformulated AKG is consumed by local gut cells during first-pass digestion. Almost none of the active nutrient survives to enter your bloodstream or travel to the tissues where senescent cells are located.

Controlled-release CaAKG solves this delivery problem.

In Rejuvant, alpha-ketoglutarate is bound to calcium to create a stable salt, which is then housed inside a specialized controlled-release tablet matrix.

This tablet protects the compound from breaking down all at once in the stomach. Instead, it releases the nutrient gradually throughout your intestinal tract. This slow, sustained release avoids overloading your digestive cells, allowing active CaAKG to enter your bloodstream in meaningful amounts.

Once in circulation, CaAKG can travel to cells throughout your body. It reaches your tissues, provides fuel to cellular enzymes, and quiets down the harmful SASP signals right at the source.

Working with your biology by managing senescent cells, rather than fighting against your body's natural defense systems, provides a sustainable path toward lasting vitality and healthy longevity.